Literature DB >> 24394345

Prion-like activity of Cu/Zn superoxide dismutase: implications for amyotrophic lateral sclerosis.

Leslie I Grad, Neil R Cashman.   

Abstract

Neurodegenerative diseases belong to a larger group of protein misfolding disorders, known as proteinopathies. There is increasing experimental evidence implicating prion-like mechanisms in many common neurodegenerative disorders, including Alzheimer disease, Parkinson disease, the tauopathies, and amyotrophic lateral sclerosis (ALS), all of which feature the aberrant misfolding and aggregation of specific proteins. The prion paradigm provides a mechanism by which a mutant or wild-type protein can dominate pathogenesis through the initiation of self-propagating protein misfolding. ALS, a lethal disease characterized by progressive degeneration of motor neurons is understood as a classical proteinopathy; the disease is typified by the formation of inclusions consisting of aggregated protein within and around motor neurons that can contribute to neurotoxicity. It is well established that misfolded/oxidized SOD1 protein is highly toxic to motor neurons and plays a prominent role in the pathology of ALS. Recent work has identified propagated protein misfolding properties in both mutant and wild-type SOD1, which may provide the molecular basis for the clinically observed contiguous spread of the disease through the neuroaxis. In this review we examine the current state of knowledge regarding the prion-like properties of SOD1 and comment on its proposed mechanisms of intercellular transmission.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24394345      PMCID: PMC7030911          DOI: 10.4161/pri.27602

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  26 in total

1.  Cellular prion protein (PrP(C)) and its role in stress responses.

Authors:  Liang Zeng; Wenquan Zou; Gongxian Wang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

2.  Efficient inhibition of infectious prions multiplication and release by targeting the exosomal pathway.

Authors:  Didier Vilette; Karine Laulagnier; Alvina Huor; Sandrine Alais; Sabrina Simoes; Romao Maryse; Monique Provansal; Sylvain Lehmann; Olivier Andreoletti; Laurent Schaeffer; Graça Raposo; Pascal Leblanc
Journal:  Cell Mol Life Sci       Date:  2015-06-06       Impact factor: 9.261

Review 3.  Neurodegenerative diseases: expanding the prion concept.

Authors:  Lary C Walker; Mathias Jucker
Journal:  Annu Rev Neurosci       Date:  2015-03-30       Impact factor: 12.449

Review 4.  RNA-binding proteins associated molecular mechanisms of motor neuron degeneration pathogenesis.

Authors:  Anna Y Tang
Journal:  Mol Biotechnol       Date:  2014-09       Impact factor: 2.695

5.  Neurotoxicity of the Cyanotoxin BMAA Through Axonal Degeneration and Intercellular Spreading.

Authors:  Vanessa X Tan; Benjamin Lassus; Chai K Lim; Philippe Tixador; Josquin Courte; Alban Bessede; Gilles J Guillemin; Jean-Michel Peyrin
Journal:  Neurotox Res       Date:  2017-08-25       Impact factor: 3.911

Review 6.  Application of yeast to studying amyloid and prion diseases.

Authors:  Yury O Chernoff; Anastasia V Grizel; Aleksandr A Rubel; Andrew A Zelinsky; Pavithra Chandramowlishwaran; Tatiana A Chernova
Journal:  Adv Genet       Date:  2020-05-04       Impact factor: 1.944

7.  Endogenous macrophage migration inhibitory factor reduces the accumulation and toxicity of misfolded SOD1 in a mouse model of ALS.

Authors:  Marcel F Leyton-Jaimes; Clara Benaim; Salah Abu-Hamad; Joy Kahn; Amos Guetta; Richard Bucala; Adrian Israelson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-22       Impact factor: 11.205

8.  Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1.

Authors:  Adrian Israelson; Dara Ditsworth; Shuying Sun; SungWon Song; Jason Liang; Marian Hruska-Plochan; Melissa McAlonis-Downes; Salah Abu-Hamad; Guy Zoltsman; Tom Shani; Marcus Maldonado; Anh Bui; Michael Navarro; Huilin Zhou; Martin Marsala; Brian K Kaspar; Sandrine Da Cruz; Don W Cleveland
Journal:  Neuron       Date:  2015-03-19       Impact factor: 17.173

9.  Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.

Authors:  Gretchen M Thomsen; Genevieve Gowing; Jessica Latter; Maximus Chen; Jean-Philippe Vit; Kevin Staggenborg; Pablo Avalos; Mor Alkaslasi; Laura Ferraiuolo; Shibi Likhite; Brian K Kaspar; Clive N Svendsen
Journal:  J Neurosci       Date:  2014-11-19       Impact factor: 6.167

Review 10.  Prion-like properties of disease-relevant proteins in amyotrophic lateral sclerosis.

Authors:  S Bräuer; V Zimyanin; A Hermann
Journal:  J Neural Transm (Vienna)       Date:  2018-02-08       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.